Login / Signup

Structure and Inhibitor Binding Characterization of Oncogenic MLLT1 Mutants.

Xiaomin NiAllyn T LondreganDafydd R OwenStefan KnappApirat Chaikuad
Published in: ACS chemical biology (2021)
Dysfunction of YEATS-domain-containing MLLT1, an acetyl/acyl-lysine dependent epigenetic reader domain, has been implicated in the development of aggressive cancers. Mutations in the YEATS domain have been recently reported as a cause of MLLT1 aberrant reader function. However, the structural basis for the reported alterations in affinity for acetylated/acylated histone has remained elusive. Here, we report the crystal structures of both insertion and substitution mutants present in cancer, revealing significant conformational changes of the YEATS-domain loop 8. Structural comparison demonstrates that not only did such alteration alter the binding interface for acetylated/acylated histones, but the sequence alterations in the loop in T1 mutant may enable dimeric assembly consistent with inducing self-association behavior. Nevertheless, we show that also the MLLT1 mutants can be targeted by developed acetyllysine mimetic inhibitors with affinities similarly to wild-type. Our report provides a structural basis for the altered behaviors and a potential strategy for targeting oncogenic MLLT1 mutants.
Keyphrases
  • wild type
  • structural basis
  • transcription factor
  • dna methylation
  • cancer therapy
  • gene expression
  • dna binding
  • oxidative stress
  • squamous cell carcinoma
  • young adults
  • squamous cell
  • fatty acid